Library
PubMed
research article
Professional

[Prevalence of blood eosinophilia in adults with COPD according to the cut-off point].

Source: PubMed, NCBI / U.S. National Library of Medicine

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)Bedolla-Barajas Martín, Morales-Romero Jaime, Bedolla-Pulido Tonantzin Isis, et al.Published 1/1/2021Last synced 8/13/2026Status: syncedPMID: 34634844DOI: 10.29262/ram.v67i3.893

To determine the prevalence of blood eosinophilia in adults with chronic obstructive pulmonary disease (COPD) according to different cut-off points. A cross-sectional study was carried out in patients with COPD. The frequency of blood eosinophilia was determined by absolute (cells/ &#xb5;L) and relative (%) eosinophil count. Multivariate methods were used in order to identify the associated factors. 81 patients were included; the mean age was 71.9 &#xb1; 9.8 years; 46 (57%) of the patients were men. The prevalence of eosinophilia for the cut-off points of &#x2265; 100, &#x2265; 150, &#x2265; 200, &#x2265; 300, and &#x2265; 400 cells/&#xb5;L was of 64.2%, 37.0%, 16.1%, and 9.9% respectively. Out of 81 patients, 34 (42%) had a relative eosinophil concentration of &#x2265; 2%; 21 (25.9%) &#x2265; 3%; 14 patients (17.3%) had &#x2265; 4%; and 10 patients (12.3%) had &#x2265; 5%. Eosinophilia of &#x2265; 100 cells/&#xb5;L was associated with age of &#x2265; 80 years (OR = 6.04, p = 0.026), and with the exacerbation of COPD (OR = 9.40, p = 0.038); in contrast, eosinophilia of &#x2265; 2% was associated only with age of &#x2265; 80 years (OR = 3.73, p = 0.020). In addition, the eosinophil count of &#x2265; 100 and < 300 cells/&#xb5;L was associated with the exacerbation of COPD (OR = 11.00, p = 0.026). Our results suggest that the frequency of eosinophilia in the context of COPD shows substantial variations according to the used definition.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.